GPC3 and hepatocellular carcinoma: There was no significant difference in expression levels of GPC3 mRNA between the HCC group (7.9 ± 3.4×10-3) and healthy volunteers (6.1 ± 2.8×10-3) (p = 0.056), and between patients with chronic viral hepatitis and cirrhosis (6.7 ± 2.9×10-3) (p = 0.214).